Today DigitalHealth.London is proud to announce the latest 17 digital health companies selected for their flagship Accelerator programme. The 17 small and medium-sized enterprises (SMEs) selected for the Accelerator 2023/24 programme have digital solutions or services that have the highest potential to meet London’s NHS and social care challenges. From apps to AI robotics, remote monitoring to diagnostics, and diabetes to cancer, the solutions from these 17 companies will transform pathways across the sector.
Now in its seventh consecutive year, the DigitalHealth.London Accelerator is funded by Health Innovation Network (HIN) through its Office for Life Sciences funding and its partners, including CW+. In addition, the Accelerator will receive £185k from the UK Government through the UK Shared Prosperity Fund for some aspects of this programme.
DigitalHealth.London is passionate about the importance of diversity and inclusion in the long-term success of innovation and transformation within the NHS and is proud that 24 percent of the seventh cohort identify as being ethnic minority owned and 24 percent are either female-majority owned or there is no clear majority.
Sara Nelson, Programme Director, DigitalHealth.London, said: “We are delighted to announce the 17 digital health companies joining our seventh DigitalHealth.London Accelerator cohort. The application process for this year’s programme was extremely competitive and as such, the final 17 companies truly are the ones to watch in the digital health space. We look forward to working with them over the next year to support the NHS and social care through digital transformation.”
Rishi Das Gupta, CEO, Health Innovation Network, said: “The Health Innovation Network is proud to run the award-winning DigitalHealth.London Accelerator which supports companies develop and spread innovative technologies which can improve health and care as well as improve patient and clinician experience. I’m excited to see another 17 companies join the programme for cohort seven. We are grateful to all our partners for their support including the UK Government which has provided funding through the UK Shared Prosperity Fund and the Office for Life Sciences.”
Chris Chaney, Chief Executive, CW+, said, “We have worked closely with previous cohorts of the DigitalHealth.London Accelerator programme and are looking forward to meeting the companies joining cohort seven who are leading the charge in the field of digital health innovation. Our partnership with DigitalHealth.London has helped our Trust become one of the biggest adopters of digital innovations that improve patient care and experience.”
DigitalHealth.London’s Accelerator aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. The Accelerator has previously supported 143 high potential digital health companies across six cohorts. It works with the companies over a 12-month period, giving bespoke support and advice, a programme of expert-led workshops and events, and brokering meaningful connections between innovators and NHS organisations with specific challenges. The companies successful in getting onto the Accelerator programme have been chosen through a rigorous and highly competitive selection process, involving expert NHS and industry panel assessments, interviews, and due diligence checks.
The digital health companies selected for the 2023/24 DigitalHealth.London Accelerator programme are:
- Abtrace – Al based software delivering preventative, personalised care at population scale.
- Aide Health – Aide is a digital health service that helps patients and clinicians better understand and manage long-term conditions.
- Akara – Akara helps hospitals maximise operational efficiency using innovative technologies that increase room utilization, enhances environmental hygiene, and improves environmental sustainability.
- Kidney Beam (Workout Online Ltd) – Kidney Beam is a clinically-proven, online exercise, education and well-being platform developed for people living with chronic kidney disease.
- Bingli – By asking the right questions Bingli helps patients get the right care from the right caregiver at the right time in the most productive and cost-efficient way.
- Blinx Healthcare – PACO (Patient and Care Optimiser) is the first fully integrated solution that supports primary care in patient identification, engagement, and scheduling on the market, with the ambition to improve health inequalities and improve practice efficiencies.
- CyberLiver Ltd – AlcoChange is intended to reduce alcohol use and maintain abstinence in individuals with established alcohol-related liver disease (ArLD) and CirrhoCare is intended for assisted diagnosis, recommendations and therapeutic intervention for the management of new complications of decompensated cirrhosis.
- Florence – Florence is an app that connects healthcare organisations directly to nurses and healthcare assistants looking for extra shifts.
- Fruit Street Health Limited – Fruit Street delivers a 12-month diabetes prevention program designed to help individuals with prediabetes lose weight and reduce their risk for developing Type 2 diabetes.
- Healthy.io (UK) Ltd – Minuteful for Wound enables better, more accurate decision making in wound care management.
- Hero Health – The ultimate digital front door solution; use Hero’s communications and scheduling tools to automate workload and delight patients.
- Hippo Labs Ltd – The Hippo Recaller streamlines and automates GP Practice proactive care processes to help them more efficiently and effectively look after their patient populations.
- Mobilise – Mobilise is building a world where all unpaid carers are equipped with the knowledge, skills and emotional support to create a healthy and sustainable caring situation – so that together, we can care and thrive.
- Opto Health – A faster, safer, smarter digital triage and streaming platform for clinicians and patients for Urgent and Emergency Care.
- Perci Health Ltd – Perci Health is the first digital cancer survivorship clinic, providing personalised healthcare for people living with and beyond cancer.
- PMD Device Solutions Ltd – PMD Solutions is revolutionising respiratory outcomes by making every breath count with its novel continuous respiratory rate wearable solutions.
- TestCard Ltd – TestCard is a urinary tract infection at-home test kit and digital app that converts a mobile phone into a clinical grade scanner to read and interpret results providing an end-to-end test, triage and treat service.
For more information about each company visit: https://digitalhealth.london/cohort-7-accelerator